Cefepime(BMY-28142) - Moligand™, ≥98% , CAS No.88040-23-7

CAS: 88040-23-7 Cat. No.: C304822 Formula: C19H24N6O5S2 Peso molecolare: 480.56 Numero EC: 643-019-5
Disponibile su ordine
QUALITÀ & PUREZZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
Cefepime [USAN:INN:BAN]|CEFEPIME [USAN]|Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))-|(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|CEFEPIME [MI]|CEFEPIME [WHO-DD]|Cefepima|CEFEPIME [INN]|PYRROLIDINIUM, 1-((7-(((2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-1-METHYL-, HYDROXIDE, INNER SALT, (6R-(6.ALPHA.,7.BETA.(Z)))-|(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidinium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate|Cefepima [Spanish]|Maxipime|cefepim|CEFEPIME [VANDF]|BMY 28142|2-piperidinethanol|VNRX-5022|7beta-((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido)-3-((1-methylpyrrolidinium-1-yl)methyl)-3,4-didehydrocepham-4-carboxylate|Butidrinum [INN-Latin]|Renapime|1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-methyloxime)|cefepime|Cefepimum [Latin]|(6R,7R)-7-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-((1-methylpyrrolidinium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate|BMY-28142|Cefepime, Antibiotic for Culture Media Use Only|Cefepimum|Cefepimum (Latin)|Cefepime (USAN/INN)
Storage
Store at -20°C,Desiccated
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
200mg
C304822-200mg
—
4 Disponibile
91,89€
1g
C304822-1g
—
1 Disponibile
295,81€
Enter a quantity for the sizes you want to add.

Specifiche

Sinonimi
Cefepime [USAN:INN:BAN] | CEFEPIME [USAN] | Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))- | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-i Mostra altro
Specifiche e purezza
Moligand™, ≥98%
Condizioni di conservazione di stoccaggio
Store at -20°C,Desiccated
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Grado
Moligand™
Purezza
≥98%
Nomi e identificatori
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488195573
SMILES
C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-]
IUPAC Name
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
InChIKey
HVFLCNVBZFFHBT-ZKDACBOMSA-N
InChI
1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)/b23-12-/t13-,17-/m1/s1
Isomeri SMILES
C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]
Peso molecolare
480.56
Reaxys
10773275
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=10773275&ln=

Dati avanzati

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClasseLactams
SubclassBeta lactams
Intermediate Tree Nodes Cephems - Cephalosporins
Direct Parent3'-quaternary ammonium cephalosporins
Alternative Parents N-acyl-alpha amino acids and derivatives  2,4-disubstituted thiazoles  1,3-thiazines  2-amino-1,3-thiazoles  N-alkylpyrrolidines  Heteroaromatic compounds  Tetraalkylammonium salts  Tertiary carboxylic acid amides  Carboxylic acid salts  Azetidines  Secondary carboxylic acid amides  Amino acids  Carboxylic acids  Monocarboxylic acids and derivatives  Dialkylthioethers  Thiohemiaminal derivatives  Azacyclic compounds  Carbonyl compounds  Hydrocarbon derivatives  Organic oxides  Organic salts  Organic zwitterions  Organopnictogen compounds  Primary amines  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents 3'-quaternary ammonium cephalosporin - N-acyl-alpha amino acid or derivatives - Alpha-amino acid or derivatives - 2,4-disubstituted 1,3-thiazole - Meta-thiazine - N-alkylpyrrolidine - 1,3-thiazol-2-amine - Tertiary carboxylic acid amide - Thiazole - Quaternary ammonium salt - Pyrrolidine - Tetraalkylammonium salt - Azole - Heteroaromatic compound - Carboxylic acid salt - Carboxamide group - Amino acid - Amino acid or derivatives - Secondary carboxylic acid amide - Azetidine - Azacycle - Carboxylic acid derivative - Dialkylthioether - Carboxylic acid - Monocarboxylic acid or derivatives - Hemithioaminal - Thioether - Amine - Organopnictogen compound - Organic oxygen compound - Organic salt - Carbonyl group - Organic nitrogen compound - Organic oxide - Organic zwitterion - Organonitrogen compound - Organooxygen compound - Primary amine - Hydrocarbon derivative - Aromatic heteropolycyclic compound
DescrizioneThis compound belongs to the class of organic compounds known as 3'-quaternary ammonium cephalosporins. These are cephalosporins that are substituted at the 3'-position by a quaternary ammonium group.
External Descriptors cephalosporin - oxime O-ether
Struttura 3D
Modello di struttura chimica interattiva





Obiettivi associati (umani)
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1C Tclin Voltage-gated L-type calcium channel alpha-1C subunit (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Obiettivi associati (non umani)
bla Beta-lactamase TEM (457 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mrdA Penicillin-binding protein 2 (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mrcB Penicillin-binding protein 1B (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
blaZ Beta-lactamase (285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus durans (113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pneumoniae (31063 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Burkholderia cepacia (649 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas fluorescens (1630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas putida (467 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter cloacae (7976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus vulgaris (5823 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Providencia rettgeri (925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Providencia sp. (46 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhimurium (15756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella flexneri (1836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Haemophilus parainfluenzae (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus haemolyticus (1695 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter (437 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter calcoaceticus (618 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter sp. (243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Moraxella catarrhalis (3334 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacteriaceae (669 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Citrobacter (156 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Citrobacter koseri (193 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Citrobacter freundii (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter (462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella aerogenes (4963 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella oxytoca (929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella sp. (156 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Morganella morganii (1291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus mirabilis (3894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Providencia stuartii (425 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella (646 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serratia marcescens (3237 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella (221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella sonnei (625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aeromonas sp. (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Haemophilus influenzae (8812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pasteurella sp. (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus agalactiae (1777 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pyogenes (16140 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Meccanismi d'azione
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

8 results found

Lot NumberCertificate TypeDataOggetto
A2626445A2626445Certificate of AnalysisJan 17, 2026 C304822
A2626446A2626446Certificate of AnalysisJan 17, 2026 C304822
I2407095I2407095Certificate of AnalysisAug 28, 2024 C304822
I2407104I2407104Certificate of AnalysisAug 28, 2024 C304822
F2325443F2325443Certificate of AnalysisJun 14, 2023 C304822
F2325444F2325444Certificate of AnalysisJun 14, 2023 C304822
F2325502F2325502Certificate of AnalysisJun 14, 2023 C304822
F2325508F2325508Certificate of AnalysisJun 14, 2023 C304822
Proprietà chimiche e fisiche
Peso molecolare480.6
XLogP3-0.100
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count10
Rotatable Bond Count6
Exact Mass480.125 Da
Monoisotopic Mass480.125 Da
Topological Polar Surface Area204.000 Ų
Heavy Atom Count32
Formal Charge0
Complexity869.000
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds1
Covalently-Bonded Unit Count1
Sicurezza e pericoli (GHS)
Pictogrammi
GHS07,   GHS08
Segnale
Danger
Indicazioni di pericolo

H317:May cause an allergic skin reaction

H334:May cause allergy or asthma symptoms or breathing difficulties if inhaled

Precauzioni

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P272:Contaminated work clothing should not be allowed out of the workplace.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P284:[In case of inadequate ventilation] Wear respiratory protection.

P321:Specific treatment (see ... on this label).

P302+P352:IF ON SKIN: wash with plenty of water.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention.

P362+P364:Take off contaminated clothing and wash it before reuse.

P501:Dispose of contents/container to an approved waste disposal plant.

P342+P316:If experiencing respiratory symptoms: Get emergence medical help immediately.

Reaxys
10773275
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=10773275&ln=
Citations of This Product
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

Item-specific, validated protocols are not provided for this SKU. The following are general, literature‑style research procedures; adapt to your system.

  • Preparation of stock solutions (research use)

    • Dissolve cefepime in pre‑chilled acetate or citrate buffer (10–50 mM, pH 4.5–5.5) to 10–50 mg/mL. Filter sterilize (0.22 μm) if sterility is required. Aliquot (single‑use) and store at −20 °C to −80 °C protected from light
  • MIC assay setup (broth microdilution; research only)

    • Prepare 2× working stocks in sterile medium; perform two‑fold serial dilutions across the desired range (e.g., 0.03–64 μg/mL)
    • Inoculate with standardized cell density (e.g., 5×10^5 CFU/mL final), incubate under organism‑appropriate conditions, and read turbidity after 18–24 h. Include growth and sterility controls
  • β‑Lactamase kinetics (research only)

    • Use buffered assay (e.g., 50 mM phosphate or MES, pH 6.0–7.0) at controlled temperature (25–37 °C); monitor hydrolysis by UV (ΔA at appropriate λ) or LC‑MS. Determine kcat/KM by initial‑rate methods
  • LC‑MS reference standard use

    • Prepare fresh standards in water or water:MeOH (80:20) with 5–10 mM ammonium formate, pH ~4.5. Store on autosampler at 4–8 °C and limit sequence length to minimize degradation

Note: These are illustrative procedures for research use only. Validate and document conditions under your laboratory QA system.

Biological Roles

Literature (general; not a product specification)

  • Mechanistic class: β‑lactam (cephalosporin) that targets bacterial cell wall biosynthesis by acylating penicillin‑binding proteins (PBPs), leading to inhibition of transpeptidation within peptidoglycan assembly
  • Zwitterionic design: the C‑3 quaternary ammonium and C‑4 carboxylate confer zwitterionic character, enhancing outer‑membrane permeation in Gram‑negative organisms and influencing protein interaction profiles
  • Enzyme interactions: substrate for serine β‑lactamases; kinetic parameters can be used to benchmark enzyme variants and inhibitor efficacy in research
  • Resistance mechanisms studied in research: β‑lactamase hydrolysis (including AmpC and ESBL families), altered porin influx/efflux, and PBP mutations; cefepime is frequently used as a probe in mechanistic and surveillance studies
  • Physicochemical implications: high polarity and hydrogen-bonding capacity lead to strong interactions with PBPs and periplasmic targets; stability and activity are pH‑dependent because β‑lactam hydrolysis accelerates under basic conditions

Use context

  • Suitable as a research ligand/standard in microbiology, enzymology, structural biology, and analytical chemistry to interrogate cell wall biosynthesis pathways and β‑lactamase function

Note: No clinical or therapeutic claims are made here. All discussion pertains to laboratory research contexts only.

Buffer Applications

Cefepime solutions are best prepared in aqueous media that balance solubility with β‑lactam stability.

  • Recommended pH window (literature): pH ~4–6 provides improved stability versus neutral/alkaline media

  • Suitable buffer systems (research use)

    • Acetate buffer: 10–50 mM, pH 4.5–5.5; excellent for stock preparation and stability studies
    • Citrate buffer: 10–50 mM, pH 4.0–6.0; useful for forced‑degradation mapping across a stability window
    • MES buffer: 10–50 mM, pH 5.5–6.5; balances stability with compatibility for many bioassays
    • For LC‑MS: ammonium acetate/formate (2–20 mM) adjusted to pH 4–5 improves MS compatibility
  • Practical preparation tips

    • Dissolve solid directly in pre‑chilled buffer to target concentration (e.g., 1–10 mg/mL), filter (0.22 μm) if sterility is required
    • Avoid phosphate at high pH; if phosphate is necessary, maintain pH ≤6 and minimize hold times
    • Store aliquots at −20 °C to −80 °C; avoid repeated freeze–thaw cycles
  • Stability checks

    • Monitor by HPLC‑UV (e.g., 254–280 nm) or LC‑MS; include time‑zero reference
    • Include stress conditions (light, heat, pH) to benchmark degradation pathways for your matrix

Note: Exact buffer composition and concentration should be optimized for your assay; verify compatibility with cells/enzymes if used in biological systems.

Green Alternatives

As a bioactive analyte rather than a process solvent/reagent, “green alternatives” focus on greener media and analytical conditions.

  • Greener dissolution media

    • Prefer aqueous buffers (acetate/citrate at pH 4–6) over organic solvent–rich vehicles
    • Use minimal DMSO as co‑solvent only when necessary (≤5–10% v/v), recognizing DMSO’s favorable but not perfect green profile
  • Greener chromatography

    • Favor water‑rich mobile phases with methanol (biobased option available) instead of acetonitrile when method performance allows
    • Employ volatile, low‑toxicity buffers (ammonium formate/acetate) at modest ionic strength; avoid phosphate when waste minimization or MS‑compatibility is desired
  • Sample handling

    • Prepare concentrated aqueous stocks to reduce solvent consumption; store in small aliquots to minimize waste from repeated thaw/freeze cycles
    • Conduct forced‑degradation studies at micro-scale to reduce chemical footprint while still mapping stability

Tradeoffs

  • Water‑rich methods improve sustainability but may lengthen run times or broaden peaks; optimizing column chemistry (e.g., polar‑embedded or mixed‑mode phases) can restore performance
  • Methanol can increase viscosity/backpressure; temperature optimization or shorter columns may be needed

Summary

  • Choose aqueous, mildly acidic conditions for most uses of cefepime; reserve organic solvents for analytical modifiers. This approach improves safety, reduces VOCs, and aligns with green chemistry principles without compromising data quality.
Pharmaceutical Uses

No therapeutic claims are made. The following pertains to pharmaceutical research, development, and analytical quality control contexts only.

  • Role in R&D and QC

    • Reference standard for method development/validation (HPLC/LC‑MS) of β‑lactams in substance and product matrices
    • System suitability and calibration compound for potency assays and content uniformity studies in research laboratories
    • Stress testing agent to establish stability‑indicating methods (acid/base, thermal, photolysis, oxidative)
  • Formulation research

    • Solubility and stability assessments in aqueous vehicles (pH 4–6) to guide preformulation decisions
    • Compatibility studies with excipients, container–closure systems, and sterilization modalities
  • Regulatory notes (general)

    • Compendial monographs may exist for specific salt/hydrate forms; verify the exact form of this item on the CoA/Spec Sheet before using compendial methods or acceptance criteria
  • Handling for formulation studies

    • Prepare fresh solutions, protect from light, and minimize residence time at elevated temperature or alkaline pH
    • Use low‑binding plastics/glassware if adsorption is suspected; confirm with recovery studies

Always confirm the exact salt/hydrate and potency of this item via the CoA before using it as a primary or secondary standard in any regulated workflow.

Physical Properties

Item-specific specifications

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

Literature/typical properties for reference (not product specifications)

  • Physical state: hygroscopic solid; typically off‑white to pale yellow depending on salt/hydrate and purity
  • Ionization/charge: zwitterionic near neutral pH (permanent cation at C‑3; carboxylate anion)
  • Solubility: high in water and aqueous buffers; limited in most aprotic organic solvents; solubility generally increases at mildly acidic pH (~pH 4–6)
  • pKa (approx., literature for cephalosporins of this class): carboxylate pKa ~2–3; side‑chain/basic centers apparent pKa in the 6–8 range; quaternary ammonium is permanently charged
  • LogP/LogD: low logP; logD strongly pH‑dependent due to zwitterionic nature
  • UV profile: β‑lactams exhibit π→π* bands in the near‑UV; exact λmax depends on solvent and salt form (check CoA/method)
  • Thermal behavior: decomposes before boiling; β‑lactam is sensitive to elevated temperature and basic pH
  • Stability notes: subject to hydrolytic ring opening accelerated at alkaline pH; more stable at pH ~4–6; sensitive to prolonged light exposure and metal-catalyzed degradation

Always verify numeric values (e.g., exact solubility, pKa, λmax, water content) on the CoA/Spec Sheet for this specific lot/item.

Quality and Grades
  • Item grade: Moligand™

    • Description (general): Moligand™ denotes research‑grade small molecules suitable for biochemical/biophysical studies, ligand screening, structural biology, assay development, and method validation. Materials are prepared and packaged to minimize adventitious moisture and degradation, aligning with typical expectations for high‑purity research reagents.
  • Purity/content specifics for this SKU: Not specified for this item; refer to CoA/Spec Sheet.

  • Stabilizers/antioxidants: Not specified for this item; refer to CoA/Spec Sheet.

  • What this means for users working with cefepime

    • Expect material intended for research use (not for human or veterinary use). Suitable for enzymology (e.g., β‑lactamase kinetics), PBP binding assays, microbiology research controls, and chromatographic reference standardization.
    • Cephalosporins are moisture‑ and pH‑sensitive; lot-specific data (assay, related substances, water, residual solvents) should be verified on the CoA to plan storage and analytical acceptance criteria.
    • UV absorbance background and LC‑MS compatibility are typically appropriate for method development; verify UV cutoff/impurity profile on the CoA when using as a calibration or system suitability standard.
  • Documentation and compliance

    • Certificate of Analysis (CoA) provides lot-specific purity, identity (e.g., HPLC, NMR, MS), and when applicable, residual solvent and water content. Always consult the CoA/Spec Sheet for specification limits.
    • Research Use Only: not intended for diagnostic or therapeutic applications.
Reaction and Applications

This product is primarily used as a bioactive research ligand/standard rather than as a synthetic reagent. Applicable research uses include:

  • Microbiology research controls

    • Use as a reference compound in susceptibility testing panels, quality control of media, and method development for antimicrobial assays (e.g., MIC determinations in research settings)
  • Enzymology and mechanism studies

    • Substrate/inhibitor for β‑lactamases to study hydrolysis kinetics and inhibitor evaluation
    • Probing penicillin‑binding proteins (PBPs) via acylation of the active‑site serine (mechanistic covalent intermediate)
  • Analytical chemistry

    • LC‑UV/LC‑MS method development and validation for β‑lactams; system suitability and calibration standards; stress testing (acid/base, heat, light) to map degradation products
  • Structural biology/biophysics

    • Ligand for binding studies (ITC, SPR, DSF) with PBPs, porins, and β‑lactamases; docking and MD benchmarking of zwitterionic scaffolds

Practical tips

  • Prepare fresh aqueous stocks (pH 4–6) immediately before experiments; aliquot and freeze for longer studies
  • Minimize exposure to basic pH and elevated temperature; protect from light
  • For LC‑MS, use volatile buffers (ammonium acetate/formate, pH ~4–5) and minimize dwell at high pH to reduce on‑column degradation

Note: No medical/clinical use is implied; all applications are for laboratory research only.

Reaction Conditions

Because cefepime is a bioactive analyte rather than a synthetic reagent, “reaction conditions” are most relevant to its stability and to mild derivatizations used in analytical probe preparation. The following are literature‑style generalities, not product specifications.

  • Stability/degradation studies

    • Acidic: relatively stable at pH 4–6, room temperature; slow hydrolysis observed over days
    • Neutral: increased hydrolysis; store cold and minimize hold times
    • Basic: rapid β‑lactam ring opening; degradation observable within minutes to hours depending on pH and temperature
    • Oxidative/light: photolabile; protect from strong light; avoid oxidants
  • Mild conjugations (if needed)

    • Aqueous amide couplings at low temperature using water‑compatible carbodiimides (e.g., EDC) with NHS activation near pH 5–6; brief reaction times; immediate purification to limit hydrolysis
    • Ion‑pairing or salt formation under mildly acidic conditions to aid preparative handling without damaging the β‑lactam
  • Analytical methods

    • HPLC: reversed‑phase, water/methanol or water/acetonitrile with 0.05–0.1% formic acid or 5–20 mM ammonium acetate, column temp 25–40 °C; detect at 254–280 nm or by MS
    • LC‑MS: use soft ionization (ESI), source set to minimize in‑source hydrolysis; avoid high‑pH mobile phases

Always verify specific conditions for your matrix and instrumentation, and confirm stability via pilot runs before large studies.

Safety and Handling

Item-specific hazard information

  • Signal Word: Not specified for this item; refer to SDS.
  • H‑Statements: Not specified for this item; refer to SDS.
  • GHS Classification/Pictograms: Not specified for this item; refer to SDS.

General safety guidance (literature/typical for β‑lactams; not product-specific)

  • Sensitization: β‑lactams can cause allergic reactions in sensitized individuals; avoid skin contact and inhalation of dust/aerosols. Handle in a fume hood or ventilated enclosure.
  • PPE: laboratory coat, suitable gloves (nitrile), safety glasses; use a dust mask/respirator if aerosolization cannot be avoided per risk assessment.
  • Handling: minimize exposure to moisture; prepare solutions fresh at appropriate pH (often pH 4–6 for stability). Avoid strong bases, strong acids, and nucleophiles that promote ring opening.
  • Incompatibilities: alkaline solutions, strong reducing or oxidizing agents, and metal ions that may catalyze degradation; avoid prolonged light exposure.
  • First aid (overview; defer to SDS): in case of skin/eye contact, rinse with water for ≥15 minutes; remove contaminated clothing. If inhaled, move to fresh air. If ingested or in case of any adverse symptoms, seek medical attention.
  • Spill/leak: avoid dust generation; collect with inert absorbent; decontaminate with aqueous buffer at mildly acidic pH; dispose according to local regulations.
  • Fire: not highly flammable as a solid; in a fire, toxic fumes may form (e.g., NOx, SOx); use water spray, CO2, dry chemical, or foam as appropriate.

Always consult the SDS for authoritative, item-specific hazard classifications and response measures.

Solvent Selection

Cefepime is a polar, zwitterionic cephalosporin. Solvent choice should preserve β‑lactam integrity while delivering required concentration and compatibility with your assay.

  • Polarity/miscibility (literature, general)

    • Highly soluble in water and aqueous buffers; solubility enhanced at mildly acidic pH (~4–6)
    • Limited solubility in most aprotic organic solvents (e.g., acetonitrile, DMSO) compared with water; small aliquots of DMSO can be used as co‑solvent if required by the assay
    • Practically insoluble in nonpolar solvents (e.g., hexanes, toluene)
  • Practical choices

    • Primary: water for injection (WFI‑quality water for analytical work), deionized water, or buffered aqueous media (acetate, citrate) at pH 4–6 for stock solutions
    • Chromatography: water with small % of acetonitrile or methanol; add volatile buffer (formate/acetate) to control peak shape and stability. Avoid high pH mobile phases
    • Enzymology/microbiology: aqueous stocks diluted into growth media or enzyme buffers shortly before use
  • Small comparison (general)

    • Water/buffer (pH 4–6): best stability and solubility; preferred for stocks
    • DMSO (≤10% v/v as co‑solvent): improves compatibility with certain assays but may affect biological readouts; monitor stability
    • MeCN/MeOH (as LC modifiers): enable gradient elution; keep pH mildly acidic

Tip: Filter sterilize aqueous stocks (0.22 μm) where sterile conditions are required; avoid prolonged exposure to basic conditions that accelerate hydrolysis.

Storage and Reconstitution

Item-specific conditions

  • Storage Conditions: Store at −20 °C, desiccated (per Product Data)
  • Shipped In: Ice chest + ice pads (per Product Data)

General guidance (literature; complementing item-specific directions)

  • Protection: keep tightly closed in a desiccator; protect from light. Allow container to warm to room temperature in a desiccated environment before opening to avoid condensation
  • Reconstitution
    • Solvent: use cold, oxygen‑reduced water or mildly acidic buffer (acetate/citrate, pH 4–6)
    • Concentration: prepare concentrated stocks (e.g., 10–50 mg/mL) as needed for your assay to minimize freeze–thaw cycles
    • Filtration: if sterility is required, filter through 0.22 μm PES/PTFE under low pressure and minimal exposure time
  • Aliquoting and storage of solutions
    • Aliquot into single‑use volumes; store at −20 to −80 °C. Avoid repeated freeze–thaw; discard any discolored or precipitated solutions
    • Stability: β‑lactams hydrolyze faster at neutral/alkaline pH and elevated temperature; keep solutions cold and at pH 4–6 when feasible
  • Documentation: record preparation date, pH, buffer composition, and lot number; verify concentration by UV or HPLC where accuracy is critical

Always defer to the CoA and SDS for definitive, lot‑specific instructions on storage, handling, and stability limits for this item.

Structure and Identity

Cefepime (BMY-28142) is a fourth-generation cephalosporin β‑lactam featuring a 7‑aminocephalosporanic acid core fused bicyclic ring (β‑lactam + dihydrothiazine), a C‑7 acyl side chain, and a positively charged N‑methylpyrrolidinium at the C‑3 position, rendering the molecule zwitterionic at neutral pH.

  • Item-specific registry identifiers (from Product Data)

    • SKU: C304822
    • CAS: 88040-23-7
    • PubChem CID: 5479537
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Item-specific grade and use

    • Grade/Purity: Moligand™ (research use only)
  • Literature identity (for reference; not a product specification)

    • Common names: Cefepime; BMY‑28142
    • Chemical class: Cephalosporin β‑lactam antibiotic; zwitterionic
    • Typical molecular formula (literature, base form): ~C19H24N6O5S2
    • Typical molecular weight (literature, base form): ~480.6 g/mol
  • Structural features (descriptive)

    • Fused β‑lactam ring (azetidinone) and dihydrothiazine ring (cephalosporin scaffold)
    • Carboxylate at C‑4 (acidic center) and an amidic acyl side chain at C‑7 (PBP-binding pharmacophore)
    • C‑3 quaternary N‑methylpyrrolidinium substituent (permanent cation) that enhances Gram‑negative penetration and aqueous solubility
    • Multiple heteroatoms (O, N, S) enabling strong hydrogen-bonding and ionic interactions with target proteins (PBPs) and enzymes (β‑lactamases)

Note: Exact stereochemistry and salt/hydrate state determine analytical values; consult the CoA/Spec Sheet for the definitive identity of this item.

Synthetic Utility

Cefepime is not typically used as a general synthetic building block due to its complexity, multiple sensitive functional groups (β‑lactam, amide, carboxylate), and zwitterionic nature.

  • Limited preparative chemistry roles

    • Derivatization for analytical probes (e.g., fluorescent tags) can be achieved via amide coupling at peripheral amines/carboxylate under carefully controlled, β‑lactam‑compatible conditions (low temperature, mild coupling reagents)
    • Prodrug/ester formation at the carboxylate has been explored in research to modulate physicochemical properties, but requires stringent control to avoid lactam opening
  • Retrosynthetic/degradative relevance

    • Serves as a benchmark scaffold in β‑lactam chemistry for studying stereoelectronic effects and ring‑opening mechanisms under stress conditions
  • Cautions

    • Strong bases, extended reaction times, or elevated temperatures readily open the β‑lactam
    • Metal-catalyzed conditions and nucleophile‑rich media can accelerate degradation

For general organic synthesis purposes, simpler β‑lactam or cephalosporin intermediates are preferential substrates; cefepime itself is best reserved for biological/analytical research applications.

Target Specificity

This section is typically applicable to biologics such as antibodies or targeted probes. Cefepime is a small‑molecule β‑lactam and does not possess antigen/epitope‑level target specificity data in the format used for antibodies.

  • Relevant research targets (literature, general): penicillin‑binding proteins (PBPs) and serine β‑lactamases are the principal molecular targets studied with cefepime in enzymology and mechanistic research.

For epitope/clone/isotype information, refer to antibody product listings rather than this small‑molecule reagent.

Domande frequenti

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?20 °C, desiccated. Keep the container tightly closed with desiccant — the material is moisture-sensitive.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 88040-23-7, the molecular formula is C19H24N6O5S2, and the molecular weight is 480.56 g/mol. InChIKey HVFLCNVBZFFHBT-ZKDACBOMSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.